Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

teva_canada

Tumultuous times at Teva continue, with Chairman exit

December 13, 2017 Medical Communications, Research and Development Teva, biotech, drugs, pharma, pharmaceutical

In the latest addition to a number of high profile exits from Teva, previous interim Chief Executive and the company’s …
News

Exscientia appoints Oxford Innovation Sciences founder and ex-Lansdowne CEO as Deputy Chairman

December 11, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alex Snow, Exscientia, appointment

Exscientia, an Oxford-based drug design firm which has made headlines this year for its collaboration with GlaxoSmithKline to leverage its …
Appointment
hands-600497_960_720

To succeed in emerging market medicine, anticipation and innovation are essential

December 11, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, biotech, drugs, emerging markets, pharma, pharmaceutical

Andrew Lane, Executive Vice President of Established Pharmaceuticals at Abbott, discusses the key steps to be taken when reaching out …
Feature
nhs_parliament_2_4

NHS trust boss of major hospital hands in fiery resignation notice

December 11, 2017 Medical Communications, Sales and Marketing NHS, biotech, drugs, pharma, pharmaceutical

Bob Kerslake, now former chair of King’s College hospital, London, has handed in his resignation, citing the lack of long-term …
News
top_ten_1

Top Ten most popular articles on Pharmafile.com this week

December 8, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, most read news, pharma, pharmaceutical, top ten

Despite us nearing the end of the year, the news has not been slowing down at all. Headlines across Europe …
News
roche_close

Roche Tecentriq combo effective, but is it enough?

December 8, 2017 Medical Communications, Research and Development Roche, biotech, drugs, pharma, pharmaceutical, tecentriq

When Roche announced that its combination treatment of Tecentriq, alongside its own drug Avastin and chemotherapy, successfully extended progression-free survival …
News
gilead-sciences

Gilead makes $567m strategic acquisition for next-gen CAR-T

December 8, 2017 Medical Communications, Sales and Marketing CAR-T, Cell Design Labs, Gilead, Kite, biotech, drugs, pharma, pharmaceutical

It’s only four months since Gilead completed its buy-out of Kite Pharma for $11.9 billion, but it’s already moving quickly …
News
philippines-1195394_960_720

Philippines ups pressure on Sanofi over dengue vaccine

December 8, 2017 Medical Communications Sanofi, biotech, drugs, pharma, pharmaceutical

Since Sanofi released further data from a six-year study which showed that the risk of a severe dengue reaction is …
News
upwards_graph

Sage Therapeutics stock pops on depression P2 results

December 8, 2017 Medical Communications, Research and Development Sage Therapeutics, biotech, drugs, pharma, pharmaceutical

Sage Therapeutics’ stock rocketed after it announced that Phase 2 results for its treatment for major depressive disorder (MDD) were …
News
james-levine-11206608

Fondation Ipsen announces Dr James Levine as new President

December 7, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Fondation Ipsen has announced its appointment of Dr James A Levine as its new President. The organisation was set up …
Appointment
dna-163466

Getting precision treatments over the line will be a team effort, not an individual bolt for glory

December 7, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Prostate Cancer UK, biotech, drugs, pharma, pharmaceutical, prostate cancer

We’ve finally reached the starter’s block when it comes to precision medicine approaches to prostate cancer, but Dr Matthew Hobbs, …
Feature
Drug R&D

Clinical trial transparency research reveals progress, but more to be done

December 7, 2017 Medical Communications biotech, clinical trials, drugs, pharma, pharmaceutical

Bioethics international, a non-profit organisation, has published its second annual index ranking pharma companies by the transparency of data from …
News
aaeaaqaaaaaaaadzaaaajda2mmvkoduzltaxndctngywns1iztq3lwm3mtg3mzk0njnkyw

Veeva launches upgrade to Veeva CRM Engage

December 6, 2017 Medical Communications Zinc systems, biotech, drugs, pharma, pharmaceutical, veeva

Veeva took the opportunity at its European Commercial & Medical Summit to reveal the latest upgrade to its Veeva CRM …
News
nhs_sign

NHS talking therapies for mental health hit a high with 1.4 million referrals

December 5, 2017 Manufacturing and Production, Medical Communications NHS, anxiety, depression, mental illness, pharma

New data has revealed that the number of UK patients seeking talking therapies on the NHS is on the rise, …
News
pcpharma_linkedin_banner

ProcureCon Pharma 2018

December 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ProcureCon, biotech, drugs, pharma, pharmaceutical

We are proud to be partnering with the ProcureCon Pharma 2018, the only event in Europe for senior pharma procurement …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026